389 related articles for article (PubMed ID: 23303625)
1. Trends in esophageal adenocarcinoma incidence and mortality.
Hur C; Miller M; Kong CY; Dowling EC; Nattinger KJ; Dunn M; Feuer EJ
Cancer; 2013 Mar; 119(6):1149-58. PubMed ID: 23303625
[TBL] [Abstract][Full Text] [Related]
2. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends.
Thrift AP; Whiteman DC
Ann Oncol; 2012 Dec; 23(12):3155-3162. PubMed ID: 22847812
[TBL] [Abstract][Full Text] [Related]
3. Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007.
Abrams JA; Sharaiha RZ; Gonsalves L; Lightdale CJ; Neugut AI
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):183-6. PubMed ID: 21127287
[TBL] [Abstract][Full Text] [Related]
4. The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.
Kong CY; Nattinger KJ; Hayeck TJ; Omer ZB; Wang YC; Spechler SJ; McMahon PM; Gazelle GS; Hur C
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2450-6. PubMed ID: 21930957
[TBL] [Abstract][Full Text] [Related]
5. Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling.
Kong CY; Kroep S; Curtius K; Hazelton WD; Jeon J; Meza R; Heberle CR; Miller MC; Choi SE; Lansdorp-Vogelaar I; van Ballegooijen M; Feuer EJ; Inadomi JM; Hur C; Luebeck EG
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):997-1006. PubMed ID: 24692500
[TBL] [Abstract][Full Text] [Related]
6. Trends in Esophageal Cancer Mortality and Stage at Diagnosis by Race and Ethnicity in the United States.
Corona E; Yang L; Esrailian E; Ghassemi KA; Conklin JL; May FP
Cancer Causes Control; 2021 Aug; 32(8):883-894. PubMed ID: 34003396
[TBL] [Abstract][Full Text] [Related]
7. Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands.
Kroep S; Lansdorp-Vogelaar I; Rubenstein JH; Lemmens VE; van Heijningen EB; Aragonés N; van Ballegooijen M; Inadomi JM
Am J Gastroenterol; 2014 Mar; 109(3):336-43; quiz 335, 344. PubMed ID: 24343546
[TBL] [Abstract][Full Text] [Related]
8. Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997-2014.
Islami F; DeSantis CE; Jemal A
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):429-439. PubMed ID: 29902641
[TBL] [Abstract][Full Text] [Related]
9. Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis.
He H; Chen N; Hou Y; Wang Z; Zhang Y; Zhang G; Fu J
Thorac Cancer; 2020 May; 11(5):1121-1128. PubMed ID: 32154652
[TBL] [Abstract][Full Text] [Related]
10. Trends in Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma Incidence in the United States from 1992 to 2019.
Liu KS; Raza SA; El-Serag HB; Thrift AP
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551535
[TBL] [Abstract][Full Text] [Related]
11. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.
Njei B; McCarty TR; Birk JW
J Gastroenterol Hepatol; 2016 Jun; 31(6):1141-6. PubMed ID: 26749521
[TBL] [Abstract][Full Text] [Related]
12. Esophageal adenocarcinoma incidence: are we reaching the peak?
Pohl H; Sirovich B; Welch HG
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1468-70. PubMed ID: 20501776
[TBL] [Abstract][Full Text] [Related]
13. The epidemic of esophageal adenocarcinoma.
el-Serag HB
Gastroenterol Clin North Am; 2002 Jun; 31(2):421-40, viii. PubMed ID: 12134611
[TBL] [Abstract][Full Text] [Related]
14. Trends in esophageal cancer incidence by histology, United States, 1998-2003.
Trivers KF; Sabatino SA; Stewart SL
Int J Cancer; 2008 Sep; 123(6):1422-8. PubMed ID: 18546259
[TBL] [Abstract][Full Text] [Related]
15. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015.
Castro C; Bosetti C; Malvezzi M; Bertuccio P; Levi F; Negri E; La Vecchia C; Lunet N
Ann Oncol; 2014 Jan; 25(1):283-90. PubMed ID: 24356640
[TBL] [Abstract][Full Text] [Related]
16. Subjects with prostate cancer are less likely to develop esophageal cancer: analysis of SEER 9 registries database.
Cooper SC; Trudgill NJ
Cancer Causes Control; 2012 Jun; 23(6):819-25. PubMed ID: 24251326
[TBL] [Abstract][Full Text] [Related]
17. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.
Matsuno K; Ishihara R; Ohmori M; Iwagami H; Shichijyo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T; Morishima T; Miyashiro I
J Gastroenterol; 2019 Sep; 54(9):784-791. PubMed ID: 30927083
[TBL] [Abstract][Full Text] [Related]
18. Emerging trends in hepatocellular carcinoma incidence and mortality.
Njei B; Rotman Y; Ditah I; Lim JK
Hepatology; 2015 Jan; 61(1):191-9. PubMed ID: 25142309
[TBL] [Abstract][Full Text] [Related]
19. Cancers with increasing incidence trends in the United States: 1999 through 2008.
Simard EP; Ward EM; Siegel R; Jemal A
CA Cancer J Clin; 2012; 62(2):118-28. PubMed ID: 22281605
[TBL] [Abstract][Full Text] [Related]
20. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
Saad AM; Turk T; Al-Husseini MJ; Abdel-Rahman O
BMC Cancer; 2018 Jun; 18(1):688. PubMed ID: 29940910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
